Cargando…
Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells
Nitazoxanide is a Food and Drug Administration-approved antiprotozoal drug recently demonstrated to be selectively active against quiescent and glucose-deprived tumour cells. This drug also has several characteristics that suggest its potential as a radiosensitizer. The present study aimed to invest...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867181/ https://www.ncbi.nlm.nih.gov/pubmed/35261637 http://dx.doi.org/10.3892/ol.2022.13243 |